MedPath

CLINICAL PROTOCOL A PROSPECTIVE MULTICENTER, PARALLEL GROUP STUDY WITH A SINGLE BLIND PHASE AND A DOUBLE BLIND RANDOMISED PHASE, TO EVALUATE THE EFFICACY AND SATISFACTION OF VIAGRA (SILDENAFIL CITRATE) HIGH DOSE (100MG) TITRATION COMPARED WITH 50MG DOSE, IN MEN WITH ERECTILE DYSFUNCTIO

Conditions
Erectile Dysfunction
MedDRA version: 6.1Level: PTClassification code 10061461
Registration Number
EUCTR2005-002411-25-IT
Lead Sponsor
PFIZER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
500
Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: ;Secondary Objective: ;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath